Literature DB >> 14577833

Early events in ovarian oncogenesis.

Dusica Cvetkovic1.   

Abstract

Ovarian cancer represents the most lethal of the gynecological neoplasms. The molecular and genetic events associated with early ovarian oncogenesis are still largely unknown, thus contributing to the lack of reliable biomarkers for disease detection. Since the majority of ovarian tumors are diagnosed at an advanced stage, the availability of early ovarian cancer tissue samples for molecular analyses is very limited. In this review, problems encountered in the study of early ovarian cancer are presented, along with the controversies concerning precursor lesions and stepwise progression towards ovarian malignancy. Experimental modeling in the development of ovarian cancer is also described, as well as genetic and epigenetic alterations associated with early ovarian cancer. Lastly, examples of technological advances in the study of early ovarian cancer are discussed. Hopefully, the increasing knowledge about molecular and genetic events involved in the early stages of ovarian tumorigenesis will provide the basis for management of ovarian cancer in the future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577833      PMCID: PMC239895          DOI: 10.1186/1477-7827-1-68

Source DB:  PubMed          Journal:  Reprod Biol Endocrinol        ISSN: 1477-7827            Impact factor:   5.211


  61 in total

Review 1.  The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

Authors:  L Dubeau
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

2.  E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium.

Authors:  N Auersperg; J Pan; B D Grove; T Peterson; J Fisher; S Maines-Bandiera; A Somasiri; C D Roskelley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  Early form of ovarian cancer originating in inclusion cysts. A case report.

Authors:  Y Aoki; N Kawada; K Tanaka
Journal:  J Reprod Med       Date:  2000-02       Impact factor: 0.142

4.  Cellular retinol-binding protein expression and breast cancer.

Authors:  Y S Kuppumbatti; I J Bleiweiss; J P Mandeli; S Waxman; R Mira-Y-Lopez
Journal:  J Natl Cancer Inst       Date:  2000-03-15       Impact factor: 13.506

5.  Disabled-2 inactivation is an early step in ovarian tumorigenicity.

Authors:  Z Fazili; W Sun; S Mittelstaedt; C Cohen; X X Xu
Journal:  Oncogene       Date:  1999-05-20       Impact factor: 9.867

Review 6.  Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).

Authors:  B Aunoble; R Sanches; E Didier; Y J Bignon
Journal:  Int J Oncol       Date:  2000-03       Impact factor: 5.650

7.  Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer.

Authors:  P A Kruk; A K Godwin; T C Hamilton; N Auersperg
Journal:  Gynecol Oncol       Date:  1999-05       Impact factor: 5.482

8.  In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential.

Authors:  C J Haas; J Diebold; A Hirschmann; H Rohrbach; U Löhrs
Journal:  Virchows Arch       Date:  1999-02       Impact factor: 4.064

Review 9.  Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.

Authors:  T Riman; I Persson; S Nilsson
Journal:  Clin Endocrinol (Oxf)       Date:  1998-12       Impact factor: 3.478

10.  Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?

Authors:  G C Rodriguez; D K Walmer; M Cline; H Krigman; B A Lessey; R S Whitaker; R Dodge; C L Hughes
Journal:  J Soc Gynecol Investig       Date:  1998 Sep-Oct
View more
  23 in total

1.  Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.

Authors:  Rajesh Singh; Cecil R Stockard; William E Grizzle; James W Lillard; Shailesh Singh
Journal:  Int J Oncol       Date:  2011-05-31       Impact factor: 5.650

2.  Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.

Authors:  Adam M Hawkridge; Rebecca B Wysocky; James N Petitte; Kenneth E Anderson; Paul E Mozdziak; Oscar J Fletcher; Jonathan M Horowitz; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2010-07-17       Impact factor: 4.142

3.  Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Sebastian Szubert; Rafał Moszyński; Dariusz Szpurek; Stefan Sajdak; Andrzej Tykarski; Krzysztof Książek
Journal:  Med Oncol       Date:  2016-07-18       Impact factor: 3.064

4.  Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model.

Authors:  Liliane Meunier; Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Mario Chevrette; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Transl Oncol       Date:  2010-08-01       Impact factor: 4.243

5.  Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancer.

Authors:  Dongyan Wu; Haitao Yang; Stacey J Winham; Yanina Natanzon; Devin C Koestler; Tiane Luo; Brooke L Fridley; Ellen L Goode; Yanbo Zhang; Yuehua Cui
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

6.  The role of activin A and Akt/GSK signaling in ovarian tumor biology.

Authors:  Thuy-Vy Do; Lena A Kubba; Monica Antenos; Alfred W Rademaker; Charles D Sturgis; Teresa K Woodruff
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

7.  CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.

Authors:  Erica L Johnson; Rajesh Singh; Shailesh Singh; Crystal M Johnson-Holiday; William E Grizzle; Edward E Partridge; James W Lillard
Journal:  World J Surg Oncol       Date:  2010-07-22       Impact factor: 2.754

8.  CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion.

Authors:  Erica L Johnson; Rajesh Singh; Crystal M Johnson-Holiday; William E Grizzle; Edward E Partridge; James W Lillard; Shailesh Singh
Journal:  J Ovarian Res       Date:  2010-06-17       Impact factor: 4.234

9.  STAMP alters the growth of transformed and ovarian cancer cells.

Authors:  Yuanzheng He; John A Blackford; Elise C Kohn; S Stoney Simons
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

10.  Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Kinga Matuszkiewicz; Sebastian Szubert; Rafał Moszyński; Dariusz Szpurek; Stefan Sajdak; Andrzej Tykarski; Krzysztof Książek
Journal:  Cell Oncol (Dordr)       Date:  2016-07-21       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.